Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBT: 2009-2024

Historic EBT for Innoviva (INVA) over the last 16 years, with Dec 2024 value amounting to $37.4 million.

  • Innoviva's EBT rose 1328.19% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.3 million, marking a year-over-year increase of 1883.11%. This contributed to the annual value of $37.4 million for FY2024, which is 80.74% down from last year.
  • Innoviva's EBT amounted to $37.4 million in FY2024, which was up 197.17% from -$38.5 million recorded in FY2024.
  • Innoviva's EBT's 5-year high stood at $445.3 million during FY2021, with a 5-year trough of -$52.3 million in FY2021.
  • For the 3-year period, Innoviva's EBT averaged around $67.6 million, with its median value being $2.4 million (2022).
  • Per our database at Business Quant, Innoviva's EBT spiked by 52.11% in 2020 and then tumbled by 80.74% in 2024.
  • Yearly analysis of 5 years shows Innoviva's EBT stood at $354.2 million in 2020, then reached -$52.3 million in 2021, then climbed by 25.70% to $445.3 million in 2021, then surged by 37.57% to -$32.7 million in 2022, then slumped by 35.56% to $286.9 million in 2022, then declined by 27.47% to -$41.6 million in 2023, then crashed by 32.36% to $194.1 million in 2023, then rose by 7.60% to -$38.5 million in 2024, then tumbled by 80.74% to $37.4 million in 2024.